| Trial ID: | L0348 |
| Source ID: | NCT02964715
|
| Associated Drug: |
Empagliflozin
|
| Title: |
The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes
|
| Acronym: |
--
|
| Status: |
Unknown status
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Type2 Diabetes|NAFLD
|
| Interventions: |
Drug: Empagliflozin
|
| Outcome Measures: |
Change in histological Grade as evaluated with Non-alcoholic Steatohepatitis Clinical Research Network Scoring System|Change in serum FGF 21|Change in fibroscan and elastography measure of liver stiffness|Change in Liver enzymes|Change in steatosis|Change in lobular inflammation|Change in ballooning|Change in fibrosis|Change in metabolic outcome -HbA1c|Change in metabolic outcome - fasting NEFA|Change in metabolic outcome - fasting Tg|Change in serum FGF 19|Change in serum adiponectin|Change in serum IL-6|Change in serum TNF alpha|Change in serum uric acid|Change in MRI features of NASH
|
| Sponsor/Collaborators: |
University of Malaya
|
| Gender: |
All
|
| Age: |
18 Years to 65 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
25
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
November 2016
|
| Completion Date: |
November 2018
|
| Results First Posted: |
--
|
| Last Update Posted: |
May 31, 2017
|
| Locations: |
University of Malaya, Kuala Lumpur, Wilayah Persekutuan, Malaysia
|
| URL: |
https://ClinicalTrials.gov/show/NCT02964715
|
